Table 2.
Published guidelines for the prevention of venous thromboembolism in inflammatory bowel disease patients
Scientific society (reference) | Recommendations | Type of population at risk |
European Crohn's and Colitis Organisation (ECCO)[29] | Mechanical thromboprophylaxis and/or heparin administration (UH or LMWH) | UC |
European Crohn's and Colitis Organisation (ECCO)[28] | Consider VTE prophylaxis (UH, LMWH, or fondaparinux) in all hospitalised patients | CD |
British Society of Gastroenterology (BSG)[31] | Pharmacological VTE prophylaxis for hospitalised patients with severe UC | UC |
American College of Gastroenterology (ACG)[30] | VTE prophylaxis with heparin for hospitalised patients with severe UC | UC |
American College of Chest Physicians (ACCP)[27] | Mechanical thromboprophylaxis with GCS or IPC; anticoagulant thromboprophylaxis with LMWH, UH or fondaparinux when bleeding risk decreases | Acutely ill hospitalised medical patients at increased risk of thrombosis who are bleeding or at high risk of bleeding |
GCS: Graduated compression stockings; IPC: Intermittent pneumatic compression; CD: Crohn’s disease; UC: Ulcerative colitis; VTE: Venous thromboembolism; LMWH: Low molecular-weight heparin; UH: Unfractionated heparin.